pamidronate has been researched along with Leishmaniasis in 2 studies
Leishmaniasis: A disease caused by any of a number of species of protozoa in the genus LEISHMANIA. There are four major clinical types of this infection: cutaneous (Old and New World) (LEISHMANIASIS, CUTANEOUS), diffuse cutaneous (LEISHMANIASIS, DIFFUSE CUTANEOUS), mucocutaneous (LEISHMANIASIS, MUCOCUTANEOUS), and visceral (LEISHMANIASIS, VISCERAL).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ribeiro, JM | 1 |
| Rodrigues-Alves, ML | 1 |
| Oliveira, E | 1 |
| Guimarães, PPG | 1 |
| Maria Murta Santi, A | 1 |
| Teixeira-Carvalho, A | 1 |
| Murta, SMF | 1 |
| Peruhype-Magalhães, V | 1 |
| Souza-Fagundes, EM | 1 |
| Oldfield, E | 1 |
2 other studies available for pamidronate and Leishmaniasis
| Article | Year |
|---|---|
Pamidronate, a promising repositioning drug to treat leishmaniasis, displays antileishmanial and immunomodulatory potential.
Topics: Animals; Antiprotozoal Agents; Drug Repositioning; Humans; Interleukin-10; Leishmania infantum; Leis | 2022 |
Targeting isoprenoid biosynthesis for drug discovery: bench to bedside.
Topics: Animals; Anti-Infective Agents; Bacterial Proteins; Diphosphonates; Drug Evaluation, Preclinical; Fa | 2010 |